Antibiotics – Worldwide Partnering Terms & Agreements 2014 to 2019: Deal Trends, Players & Financials

    NEXT STORY
    Turning Point Therapeutics to Host Second Quarter 2019 Conference Call
    PREV STORY
    Salarius Pharmaceuticals Enrolls First Patient in a Phase 1 Clinical Study of its Novel Inhibitor Targeting Epigenetics in Patients with Advanced Solid Tumors
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Clinical Genomics Announces the Launch of Colvera™ for Colorectal Cancer Recurrence Monitoring

    BRIDGEWATER, N.J., Dec. 20, 2016 (GLOBE NEWSWIRE) -- Clinical Genomics, a private company developing ...

    author_avatar
    NASDAQ Market News

    Syapse Hosts Inaugural Precision Medicine Council to Drive Progress in Precision Oncology

    Nation’s leading health systems convene today to share best practices and improve cancer care ...

    author_avatar
    NASDAQ Market News

    Orphazyme reports encouraging arimoclomol clinical trial top-line data in Niemann-Pick disease Type C (NPC)

    Orphazyme A/SCompany announcement                                                                                                                   No. 12/2018                                                                                                                                        Company Registration No. 32266355                                                                                                                                                                                              Arimoclomol was well-tolerated in patients ...

    author_avatar
    NASDAQ Market News